Reduced risk of head and neck second primary tumors after radiotherapy

Radiotherapy and Oncology

Volumn 93, Issue 3, 2009, Pages 559-562

  Rennemo, Erlend ^a   Zätterström, Ulf ^a   Evensen, Jan ^b   Boysen, Morten ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Field cancerization; HNSCC; Premalignant lesions; Radiotherapy; Second primary tumors

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION DOSE; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUCOUS MEMBRANE; NEOPLASMS, SECOND PRIMARY; OTORHINOLARYNGOLOGIC NEOPLASMS; PRECANCEROUS CONDITIONS; RISK;

EID: 70449638320     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.08.005     Document Type: Article

References (23)

1. Yamamoto E., Shibuya H., Yoshimura R.I., and Miura M. Site specific dependency of second primary cancer in early stage head and neck squamous cell carcinoma. Cancer 94 (2002) 2007-2014
2. Rennemo E., Zatterstrom U., and Boysen M. Impact of second primary tumors on survival in head and neck cancer: an analysis of 2,063 cases. Laryngoscope 118 (2008) 1350-1356
3. Jones A.S., et al. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 75 (1995) 1343-1353
4. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
5. Hunter K.D., Parkinson E.K., and Harrison P.R. Profiling early head and neck cancer. Nat Rev Cancer 5 (2005) 127-135
6. Slaughter D.P., Southwick H.W., and Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer 6 (1953) 963-968
7. Braakhuis B.J., Brakenhoff R.H., and Leemans C.R. Second field tumors: a new opportunity for cancer prevention?. Oncologist 10 (2005) 493-500
8. Corvo R. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 85 (2007) 156-170
9. Little M.P. Cancer after exposure to radiation in the course of treatment for benign and malignant disease. Lancet Oncol 2 (2001) 212-220
10. Warren S., and Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 16 (1932) 1358-1414
11. Bland J.M., and Altman D.G. Survival probabilities (the Kaplan-Meier method). BMJ 317 (1998) 1572
12. Singh B. Molecular pathogenesis of head and neck cancers. J Surg Oncol 97 (2008) 634-639
13. Haddad R.I., and Shin D.M. Recent advances in head and neck cancer. N Engl J Med 359 (2008) 1143-1154
14. Fletcher G.H. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer 29 (1972) 1450-1454
15. Gewirtz D.A., Holt S.E., and Elmore L.W. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem Pharmacol 76 (2008) 947-957
16. Collado M., et al. Tumour biology: senescence in premalignant tumours. Nature 436 (2005) 642
17. Roberson R.S., Kussick S.J., Vallieres E., Chen S.Y., and Wu D.Y. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer Res 65 (2005) 2795-2803
18. Beausejour C.M., et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 22 (2003) 4212-4222
19. Malard O., et al. Radiation-induced cancers of the pharynx and larynx: a study of five clinical cases. Clin Otolaryngol 27 (2002) 68-74
20. Tubiana M. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol 91 (2009) 4-15 discussion 1-3
21. Rusthoven K., Chen C., Raben D., and Kavanagh B. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis. Int J Radiat Oncol Biol Phys 71 (2008) 192-198
22. Hashibe M., et al. Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett 220 (2005) 185-195
23. Khuri F.R., et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev 10 (2001) 823-829